patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
ADLYXIN
Marketedupdated 2mo agoby Sanofi-Aventis US LLC
Approvedcommunity read0 votes
all catalysts(7)
approval · 7
Jul 27, 2016
approval
ADLYXIN (LIXISENATIDE) — FDA approval
ADLYXIN
→
Jul 30, 2021
approval
ADLYXIN (LIXISENATIDE) — FDA approval
ADLYXIN
→
Jun 10, 2022
approval
ADLYXIN (LIXISENATIDE) — FDA approval
ADLYXIN
→
Sep 28, 2023
approval
ADLYXIN (LIXISENATIDE) — FDA approval
ADLYXIN
→
Nov 1, 2024
approval
ADLYXIN (LIXISENATIDE) — FDA approval
ADLYXIN
→
May 28, 2025
approval
ADLYXIN (LIXISENATIDE) — FDA approval
ADLYXIN
→
Mar 12, 2026
approval
ADLYXIN (LIXISENATIDE) — FDA approval
ADLYXIN
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that